drugset / Trial / NCT00439374
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
Phase 3
Terminated
657 enrolled
The George Washington University Biostatistics Center
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to see if giving progesterone medication to pregnant women, who have never delivered a baby after 19 weeks of pregnancy and who have a short cervix, lowers the risk of early delivery and improves the health of their baby.
Timeline
- Start
- 2007-04
- Primary completion
- 2011-05
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 17-alpha-hydroxyprogesterone caproate | Unknown | 250 mg | Intramuscular |
Indications
No indication recorded.